{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:23:39Z","timestamp":1782926619310,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.gastha.2023.10.002","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T07:41:26Z","timestamp":1696923686000},"page":"190-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient Preferences for Ulcerative Colitis Treatment in the Middle East Region: A Discrete-Choice Experiment"],"prefix":"10.1016","volume":"3","author":[{"given":"Othman","family":"AlHarbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niazy Abu","family":"Farsakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Al-Awadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Al-Taweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inas","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Batwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Bedran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Balkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent Mert","family":"Gunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Cappelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Boeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colton","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Habjoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mosli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2023.10.002_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2023.10.002_bib2","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.3748\/wjg.v20.i46.17525","article-title":"Clinical epidemiology of ulcerative colitis in Arabs based on the Montreal classification","volume":"20","author":"Alharbi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastha.2023.10.002_bib3","first-page":"1188","article-title":"Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group","volume":"88","author":"Hanauer","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2023.10.002_bib4","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/j.1572-0241.2005.00248.x","article-title":"Delayed-release oral mesalamine at 4.8 g\/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial","volume":"100","author":"Hanauer","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2023.10.002_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7326\/0003-4819-124-2-199601150-00003","article-title":"An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group","volume":"124","author":"Hanauer","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastha.2023.10.002_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.gtc.2004.02.010","article-title":"Mesalamine derivatives in the treatment of Crohn's disease","volume":"33","author":"Harrell","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.gastha.2023.10.002_bib7","first-page":"1398","article-title":"A\u00a0randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis","volume":"97","author":"Levine","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2023.10.002_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-115-5-350","article-title":"Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study","volume":"115","author":"Sninsky","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastha.2023.10.002_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2023.10.002_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-7-13","article-title":"Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study","volume":"7","author":"Actis","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastha.2023.10.002_bib11","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s10620-006-9209-y","article-title":"The role of tacrolimus in inflammatory bowel disease: a systematic review","volume":"51","author":"Gonzalez-Lama","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastha.2023.10.002_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1748-5908-4-75","article-title":"Dual equipoise shared decision making: definitions for decision and behaviour support interventions","volume":"4","author":"Elwyn","year":"2009","journal-title":"Implement Sci"},{"key":"10.1016\/j.gastha.2023.10.002_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/CEG.S206970","article-title":"Patient and physician preferences for ulcerative colitis treatments in the United States","volume":"12","author":"Boeri","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.gastha.2023.10.002_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cgh.2019.05.010","article-title":"Variation among patients with Crohn's disease in benefit vs risk preferences and remission time equivalents","volume":"18","author":"Bewtra","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2023.10.002_bib15","first-page":"1571","article-title":"The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn's Relapse Prevention Trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2023.10.002_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","article-title":"Discrete choice experiments in health economics: past, present and future","volume":"37","author":"Soekhai","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.gastha.2023.10.002_bib17","series-title":"Stated choice methods: analysis and applications","author":"Louviere","year":"2000"},{"key":"10.1016\/j.gastha.2023.10.002_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR good research practices for Conjoint analysis task force","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.gastha.2023.10.002_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint analysis experimental design good research practices task force","volume":"16","author":"Johnson","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.gastha.2023.10.002_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00133443","article-title":"The structure of random utility models","volume":"8","author":"Manski","year":"1977","journal-title":"Theory Decis"},{"key":"10.1016\/j.gastha.2023.10.002_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1037\/h0070288","article-title":"A\u00a0law of comparative judgment","volume":"34","author":"Thurstone","year":"1927","journal-title":"Psychol Rev"},{"key":"10.1016\/j.gastha.2023.10.002_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint analysis good research practices task force","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.gastha.2023.10.002_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hec.1197","article-title":"A\u00a0comparison of approaches to estimating confidence intervals for willingness to pay measures","volume":"16","author":"Hole","year":"2007","journal-title":"Health Econ"},{"key":"10.1016\/j.gastha.2023.10.002_bib24","series-title":"Econometric analysis","author":"Greene","year":"2012"},{"key":"10.1016\/j.gastha.2023.10.002_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40271-021-00518-y","article-title":"The impact of the risk functional form assumptions on maximum acceptable risk measures","volume":"14","author":"Gonzalez","year":"2021","journal-title":"Patient"},{"key":"10.1016\/j.gastha.2023.10.002_bib26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jval.2022.01.012","article-title":"Accounting for preference heterogeneity in discrete-choice experiments: an ISPOR special interest group report","volume":"25","author":"Vass","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.gastha.2023.10.002_bib27","series-title":"Applied choice analysis","author":"Hensher","year":"2005"},{"key":"10.1016\/j.gastha.2023.10.002_bib28","series-title":"Handbook of healthcare in the Arab world","article-title":"Patient-centered care in the Middle East","author":"Webair","year":"2020"},{"key":"10.1016\/j.gastha.2023.10.002_bib29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/17474124.2018.1503052","article-title":"Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East","volume":"12","author":"Sharara","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2023.10.002_bib31","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1007\/s00464-014-4044-2","article-title":"Incorporating patient-preference evidence into regulatory decision making","volume":"29","author":"Ho","year":"2015","journal-title":"Surg Endosc"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572323001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572323001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:58:53Z","timestamp":1762646333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572323001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2772572323001619"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2023.10.002","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Preferences for Ulcerative Colitis Treatment in the Middle East Region: A Discrete-Choice Experiment","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2023.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}